SESEN BIO INC has a total of 14 patent applications. It decreased the IP activity by 83.0%. Its first patent ever was published in 2013. It filed its patents most often in EPO (European Patent Office), Australia and Brazil. Its main competitors in its focus markets pharmaceuticals and biotechnology are PHILOGEN SPA, SHASHOUA VICTOR E and INTER K PTY LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 3 | |
#2 | Australia | 2 | |
#3 | Brazil | 1 | |
#4 | Canada | 1 | |
#5 | EAPO (Eurasian Patent Organization) | 1 | |
#6 | Hong Kong | 1 | |
#7 | Hungary | 1 | |
#8 | Republic of Korea | 1 | |
#9 | Morocco | 1 | |
#10 | Mexico | 1 | |
#11 | Serbia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Zarbis-Papastoitsis Grigorios | 10 |
#2 | Tisdale Alison | 8 |
#3 | Schmidt Michael March | 7 |
#4 | Furfine Eric Steven | 6 |
#5 | Lowden Patricia | 4 |
#6 | Grigorios Zarbis-Papastoitsis | 2 |
#7 | Furfine Eric | 2 |
#8 | Patricia Lowden | 2 |
#9 | Erbe David V | 1 |
#10 | Schmidt Michael M | 1 |
Publication | Filing date | Title |
---|---|---|
AU2017223687A1 | IL-6 antagonist formulations and uses thereof |